147 related articles for article (PubMed ID: 9669394)
1. Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer.
Salvatori M; Saletnich I; Rufini V; Dottorini ME; Corsello SM; Troncone L; Shapiro B
J Nucl Med; 1998 Jul; 39(7):1202-7. PubMed ID: 9669394
[TBL] [Abstract][Full Text] [Related]
2. Differentiated thyroid cancer presenting with thyrotoxicosis due to functioning metastases.
Haq M; Hyer S; Flux G; Cook G; Harmer C
Br J Radiol; 2007 Feb; 80(950):e38-43. PubMed ID: 17495053
[TBL] [Abstract][Full Text] [Related]
3. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
Oyen WJ; Mudde AH; van den Broek WJ; Corstens FH
J Nucl Med; 1995 Apr; 36(4):613-5. PubMed ID: 7699452
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of technetium-99m pertechnetate in a patient with metastases of thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Ono Y; Satoh K; Ohkawa M; Kawasaki Y; Tanabe M
Ann Nucl Med; 1999 Oct; 13(5):357-9. PubMed ID: 10582808
[TBL] [Abstract][Full Text] [Related]
5. Accelerated thyrotoxicosis induced by iodinated contrast media in metastatic differentiated thyroid carcinoma.
Lorberboym M; Mechanick JI
J Nucl Med; 1996 Sep; 37(9):1532-5. PubMed ID: 8790212
[TBL] [Abstract][Full Text] [Related]
6. Remarkable Response of Pulmonary Metastases Rather Than Remnant Thyroid in 131I Therapy of Follicular Thyroid Cancer.
Tian T; Chen Y; Xiang Y; Liu L; Liu B
Clin Nucl Med; 2019 Apr; 44(4):327-329. PubMed ID: 30688748
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
Samuel AM; Rajashekharrao B; Shah DH
J Nucl Med; 1998 Sep; 39(9):1531-6. PubMed ID: 9744337
[TBL] [Abstract][Full Text] [Related]
8. Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases.
Kasagi K; Takeuchi R; Miyamoto S; Misaki T; Inoue D; Shimazu A; Mori T; Konishi J
Clin Endocrinol (Oxf); 1994 Mar; 40(3):429-34. PubMed ID: 8187309
[TBL] [Abstract][Full Text] [Related]
9. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
[TBL] [Abstract][Full Text] [Related]
10. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
11. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
Lin JD; Kao PF; Chao TC
Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
[TBL] [Abstract][Full Text] [Related]
13. "Hot" carcinoma of the thyroid. Case reports and comments on the literature.
Lupi A; Orsolon P; Cerisara D; Deantoni Migliorati G; Vianello Dri A
Minerva Endocrinol; 2002 Mar; 27(1):53-7. PubMed ID: 11845114
[TBL] [Abstract][Full Text] [Related]
14. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
15. Unusual initial manifestation of metastatic follicular carcinoma of the thyroid with thyrotoxicosis diagnosed by technetium Tc 99m pertechnetate scan: case report and review of literature.
Sundaraiya S; Dizdarevic S; Miles K; Quin J; Williams A; Wheatley T; Zammitt C
Endocr Pract; 2009; 15(5):458-62. PubMed ID: 19491082
[TBL] [Abstract][Full Text] [Related]
16. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
17. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
19. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.
Basaria S; Salvatori R
J Endocrinol Invest; 2002; 25(7):639-42. PubMed ID: 12150341
[TBL] [Abstract][Full Text] [Related]
20. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
